Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 22, 2000

Primary Completion Date

January 31, 2005

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

DRUG

cisplatin

DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

Trial Locations (16)

34

Instituto de Enfermedades Neoplasicas, Lima

2145

Westmead Hospital, Westmead

14642

James P. Wilmot Cancer Center, Rochester

30322

Emory University Hospital - Atlanta, Atlanta

50309

Iowa Methodist Medical Center, Des Moines

50314

Mercy Medical Center, Des Moines

74136

CCOP - Oklahoma, Tulsa

76508

CCOP - Scott and White Hospital, Temple

87131

MBCCOP - University of New Mexico HSC, Albuquerque

50316-2301

Iowa Lutheran Hospital, Des Moines

68128-4157

Alegent Health-Midlands Community Hospital, Papillion

07601

CCOP - Northern New Jersey, Hackensack

08903

Cancer Institute of New Jersey, New Brunswick

17033-0850

Milton S. Hershey Medical Center, Hershey

54307-3453

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

00936-7344

San Juan City Hospital, San Juan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00006004 - Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter